Liam Wilson

In recent years, U.S. investors have been increasingly drawn to the global sports market, particularly European soccer clubs. However, instead of targeting the marquee teams with sky-high valuations, some investors are shifting their focus to smaller clubs with lower valuations. This article explores the reasons behind this shift and analyzes the potential benefits and challenges
0 Comments
A recent secondary analysis of the STEP-HFpEF trial revealed promising results regarding the use of semaglutide 2.4 mg (Wegovy) in heart failure patients with moderately reduced and preserved ejection fraction (HFmrEF, HFpEF) associated with obesity. This analysis, presented by Dr. Javed Butler, showcased the consistent benefits of semaglutide in various subgroups during the Heart Failure
0 Comments